col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


14 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Journal of Chemotherapy
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―14 Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge Claudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, Marta Ponzano, Stefania Tigano, Sara Tita Farinella, et al. (+15)
2 [GO] 2023―Dec―04 Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases Atsushi Suzuki, Kensuke Fukumitsu, Jun Fukihara, Takuma Katano, Hisashi Kako, Yuri Maeda, et al. (+4)
3 [GO] 2023―Aug―23 Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital Chiara Russo, Luca Tagliafico, Laura Labate, Marta Ponzano, Michele Mirabella, Federica Portunato, et al. (+10)
4 [GO] 2023―Aug―22 Safety of Sotrovimab use in children with COVID-19: an Italian experience Elisabetta Venturini, Lara Fusani, Andrea Lo Vecchio, Sara Maria Scarano, Silvia Garazzino, Giulia Pruccoli, et al. (+4)
5 [GO] 2023―Apr―27 Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients Massimiliano Lanzafame, Martina Gottardi, Lorenza Guella, Lucia Collini, Giorgio Costa, Anna Guella, Sandro Vento
6 [GO] 2022―Sep―14 Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis Carmine Sellitto, Graziamaria Corbi, Nicola Bertini, Tiziana Ascione, Maria Costantino, Giuliana Scarpati, et al. (+4)
7 [GO] 2022―Jul―15 Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story Periklis Panagopoulos, Vasilis Petrakis, Grigorios Trypsianis, Dimitrios Papazoglou
8 [GO] 2022―Apr―26 Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study Pınar Ergen, M. Esra Koçoğlu, Müge Nural, Mert Ahmet Kuşkucu, Özlem Aydin, Ferda Y. İnal, et al. (+9)
9 [GO] 2021―Oct―16 Drugs and liver injury: a not to be overlooked binomial in COVID-19 M. Vitrone, F. Mele, E. Durante-Mangoni, R. Zampino
10 [GO] 2021―May―25 Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience Murat Ayhan, Hatice Odabas, Nedim Turan, Deniz Tataroglu Ozyukseler, Osman Kostek, Gulin Alkan, et al. (+2)
11 [GO] 2021―Mar―26 Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review C. Nahshon, Y. Segev, M. Schmidt, T. Bar-noy, L. Ostrovsky, O. Lavie
12 [GO] 2021―Jan―13 Therapeutic options for COVID-19: a quick review Muhammad Sani Ismaila, Faruku Bande, Aminu Ishaka, Aminatu Abubakar Sani, Karla Georges
13 [GO] 2020―Oct―13 Exploring metastatic breast cancer treatment changes during COVID-19 pandemic Palma Fedele, Antonella Ferro, Valeria Sanna, Nicla La Verde, Ida Paris, Rita Chiari
14 [GO] 2020―Jun―12 Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection Periklis Panagopoulos, Vasilis Petrakis, Maria Panopoulou, Grigorios Trypsianis, Theano Penlioglou, Ioannis Pnevmatikos, Dimitrios Papazoglou
 [1] 

14 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec